Renalytix Investor Relations Material
Latest events
Q2 2025
Renalytix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Renalytix Plc
Access all reports
Renalytix Plc is a diagnostics company specializing in the development of tests that assess kidney health. The company integrates machine learning and clinical data to create predictive diagnostics aimed at improving kidney disease treatment. It serves healthcare providers and institutions through strategic collaborations and commercialization efforts. Renalytix Plc is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
RENX
Country
🇬🇧 United Kingdom